Obrela is recognized for the third time in Gartner MDR Report
Obrela, an international cyber security services provider, today announced that has been recognized in the 2024 Gartner® Market Guide for MDR, for the third consecutive time, alongside other MDR providers.
Published in June 2024, this respected industry report includes a list of Representative Vendors. According to Gartner®, “By 2028, 50% of findings from managed detection and response providers will be focused on, or include detail on, threat exposures, up from 10% today.” Also, “MDR buyers are asking providers to extend their requirements beyond the detection of and response to threats, to include the proactive identification of threat exposures and preemptive security responses.” They also suggest “investigate whether the MDR provider’s service can align with your business-driven requirements by using RFPs and proofs of concept (POCs), and if necessary, by validating core, must-have requirements, such as data residency requirements. Determine whether it can provide actionable findings that internal teams can successfully react to, rather than settling for regurgitated technology outputs with no added analysis.”
Headquartered in the UK, Obrela’s presence in the international cyber security landscape is growing rapidly, with an expanded workforce and operations across EMEA. Obrela considers that by being recognized in this Market Guide for MDR further strengthens its commitment to excellence in delivering innovative and customer-centric cyber security solutions aiming at “keeping our clients’ business in business”
George Patsis, CEO at Obrela said: “We are honored to be recognized for the third time in a row in the latest Gartner Market Guide for MDR. We believe it is a testament to the performance of our MDR solution and exceptional customer services that have been recognized in this prestigious report alongside other international companies.”
Obrela’s MDR solution meets shifting customer needs for a provider that not only detects threats but offers proactive measures and the intelligence to address any business risks. MDR is Obrela’s flagship solution offering, encompassing Endpoint and Network detection, Cloud and Infrastructure protection as well as Brand and Operational Technology security. Obrela’s offering is vendor agnostic and comprehensively addresses the market requirements being acknowledged by multinational organizations that partner with the company to offer value added solutions to help businesses safeguard their mission critical operations.
“We are committed to holistically provide Cyber Risk Management in real time addressing the next generation challenges in the sector and offering Cybersecurity as a Service. We also feel, the inclusion of our company in the Gartner® Market Guide simply strengthens our commitment to better realize this goal.” continues George Patsis, CEO at Obrela.
Readers can use a Gartner® Market Guide to understand how the status of an emerging market aligns to their future plans. In addition, since Gartner® has published over 100 Market Guide research notes, IT and strategic leaders and investors can gain a broad view of many markets, including mature and smaller markets, in an easy-to-read format.
The Gartner® Market Guide for Managed Detection and Response Services was published on 24 June 2024 and created by Pete Shoard, Andrew Davies, Mitchell Schneider, Angel Berrios, and Craig Lawson.
Gartner®, Inc. delivers actionable, objective insight to executives and their teams.
Disclaimer
GARTNER® is a registered trademark and service mark of Gartner®, Inc. and/or its affiliates in the U.S. and internationally and is used here in with permission. All rights reserved.
Gartner® does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner® research publications consist of the opinions of Gartner® research organization and should not be construed as statements of fact. Gartner® disclaims all warranties, express or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
